Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity

v3.24.2.u1
Stockholders’ Equity
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Stockholders’ Equity

Note 9 – Stockholders’ Equity

 

Stock Dividend

 

On March 23, 2023, the Company issued a fifty percent (50%) stock dividend of the Company’s common stock to its shareholders for a stock dividend of one share of common stock for every two shares of common stock held.

 

The Company followed paragraph ASC 505-20-25 in treating its stock dividend as a stock split due to the stock dividend being greater than 25% of the shares then outstanding. As such, on March 23, 2023 and April 3, 2023, the Company issued 21,592,164 stock dividends to its shareholders for a stock dividend of one share of common stock for every two shares of common stock issued and outstanding. The Company adhered to paragraph ASC 260-10-55-12, wherein it retroactively adjusted its statement of stockholders’ equity for all presented periods to incorporate the alteration in capital structure.

 

Common stock

 

In prior years, the Company entered into several employment agreements that require the issuance of common shares for services that vest on a quarterly basis. During the period ended June 30, 2024, an aggregate of 58,496 shares with a fair value of $50,348 vested during the period and were recognized as compensation costs. As of December 31, 2023, 41,463 of shares with a fair value of $74,476 that vested under these agreements were not issued. During the period ending June 30, 2024, 16,446 shares with a fair value of $58,508 that previously vested were issued during the period. As of June 30, 2024, 25,197 shares of common stock with a fair value of $15,968 remained issuable.

 

Treasury stock

 

On August 10, 2022, the Company entered a stock purchase agreement (the “Stock Purchase Agreement”) with a private shareholder to repurchase 600,000 shares of its common stock for $2,000,000. The private shareholder transferred the shares on October 4, 2022, forming a binding agreement, which the Company placed in treasury; and on October 6, 2022, the Company wired the first $1,000,000 of the purchase price. Subsequently, on July 14, 2023, the Company entered into an amendment to the Stock Purchase Agreement that increased the number of shares of its common stock the Company would purchase to 1,300,000 shares and revised the total purchase price of the shares to $1,965,000 resulting in a $35,000 change in our obligation to purchase Treasury stock. The remaining $965,000 was paid on July 14, 2023. Upon receipt of the additional 900,000 shares, the Company also placed them in treasury. As of January 17, 2023, the Company retired the initial 600,000 shares and restored them to the status of authorized and unissued shares.

 

On June 11, 2024, the Company retired 30,000 shares with a cost of $48,362 and restored them to the status of authorized and unissued shares.

 

Employee compensation

 

On February 11, 2022 (the “Vesting Date”), the Company entered into a restricted stock award agreements (the “Award Agreement”) with eight employees for 280,000 shares of the Company’s common stock subject to the terms and to the fulfillment of the conditions set forth in the Company’s equity incentive plan. The first 20% of the restricted shares were granted and vested on February 11, 2022. An additional 20% of the restricted shares will vest on each anniversary of the Vesting Date until the fourth anniversary of the Vesting Date. The initial fair value of the awards on the date of grant was determined to be $2,942,800 which is being amortized over the 5 year vesting period. As of December 31, 2023 the unamortized amount of the award was $1,072,020. During the six months ended June 30, 2024 the Company amortized $178,670 of this amount leaving an unamortized balance of $893,350 at June 30, 2024. As of June 30, 2024, 186,000 of the shares had been vested and 132,000 of the shares had been forfeited.

 

Stock options

 

On January 2, 2024, each member of the Board was granted 22,500 options to purchase shares at $1.50 per share with a fair value of $29,595. The options vest monthly over 1 year, and may be exercised during a 10-year term. In the aggregate, 112,500 options were granted with a fair value of $147,975. During the six months ended June 30, 2024, the Company recognized $73,990 of compensation cost relating to the vesting of these options and $73,990 remained unvested which will be amortized over the remainder of 2024.

 

For the six months ended June 30, 2024 and 2023, the Company’s stock option compensation expenses amounted to $73,990 and $266,806, respectively.

 

The fair value of the stock options issued during the periods was determined using the Black-Scholes option pricing model with the following assumptions:

     
    June 30, 2024  
Risk-free interest rate     3.94%  
Expected life of the options     5.5 years  
Expected volatility     126.73%  
Expected dividend yield     0%  

 

The following is a summary of the option activity from December 31, 2023 to June 30, 2024:

                       
    Number of Options     Weighted average exercise price     Weighted Average Remaining Contractual Life     Aggregate Intrinsic Value  
Outstanding at December 31, 2023     513,874     $ 4.05       7.25        
Granted     112,500     $ 1.50              
Exercised                        
Cancelled or forfeited                        
Outstanding at June 30, 2024     626,374     $ 3.60       7.25        
Vested as of June 30, 2024     570,124     $ 3.80       7.03        
Exercisable as of June 30, 2024     570,124     $ 3.80       7.03